Company intelligence / Profile preview

Dovetail Genomics

Scotts Valley, California, United Statescantatabio.com ↗

Ownership: Private
Employees: ~22
Development stage: Commercial

Overview

Dovetail Genomics provides advanced genomic analysis solutions using proprietary proximity ligation technologies. Their platforms enable high-resolution detection of structural variants and comprehensive genome assembly for applications in cancer research, precision medicine, epigenetics, and more. The company has demonstrated the ability to detect somatic variation at low variant allele frequencies using standard NGS platforms—empowering researchers working with challenging sample types like FFPE tissue.

Industry: Molecular Diagnostics

Partnerships

HudsonAlpha Institute for Biotechnology

Beyond the preview

Go deeper on Dovetail Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dovetail Genomics.

Explore the full profile